MannKind Receives “Market Perform” Rating from Wells Fargo (MNKD)

MannKind (NASDAQ: MNKD)‘s stock had its “market perform” rating reaffirmed by research analysts at Wells Fargo in a report released on Monday.

Shares of MannKind traded up 11.44% during mid-day trading on Monday, hitting $3.41. MannKind has a 52 week low of $1.57 and a 52 week high of $3.11. The stock’s 50-day moving average is currently $2.55. The company’s market cap is $781.7 million.

MannKind last issued its quarterly earnings data on Monday, February 11th. The company reported ($0.23) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.04. During the same quarter last year, the company posted ($0.30) earnings per share. On average, analysts predict that MannKind will post $-0.47 earnings per share for the current fiscal year.

Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks reiterated a “neutral” rating on shares of MannKind in a research note to investors on Wednesday, February 13th. They now have a $2.50 price target on the stock.

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer.

http://localizedusa.com/2013/03/11/mannkind-receives-market-perform-rating-from-wells-fargo-mnkd/